The Worldwide Scar Treatment Market is Projected to reach USD 39 Billion by 2028, at a CAGR of 9.2%

Scar Treatment Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Scar Treatment Market size is expected to reach $39 billion by 2028, rising at a market growth of 9.2% CAGR during the forecast period.

The Hospitals market is exhibiting a CAGR of 8.8 % during the forecast period. This is because the establishments in question make use of innovative equipment and supplies, as well as the fact that they stock their shelves with cutting-edge goods in order to cure scars. The great majority of scar treatments are offered in hospitals, providing patients with a selection of different techniques for minimizing or eliminating the appearance of the scar.

The Topical Products market is leading the segment in the Global Scar Treatment Market by Product in 2021; thereby, achieving a market value of $16.3 billion by 2028. Scars may be treated using topical creams, gels, and silicone sheets, all of which are available as over-the-counter (OTC) medicines. These treatments are available to consumers. Scars may be treated with minimum discomfort using laser goods, which provide a non-invasive and painless treatment alternative.

The Hypertrophic & Keloid Scars market is showcasing a CAGR of 9.4% during (2022 - 2028). The hypertrophic scar is a thick and raised scar that is an atypical reaction to wound curative treatment. During the healing process, an excessive amount of a protein called collagen may form in the skin, which can lead to the formation of a keloid.

The North America market dominated the Global Scar Treatment Market by Region in 2021; thereby, achieving a market value of $13.2 billion by 2028. The Europe market is poised to grow at a CAGR of 8.6% during (2022 - 2028). Additionally, The Asia Pacific market would witness a CAGR of 10% during (2022 - 2028).

Full Report: https://www.kbvresearch.com/scar-treatment-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Smith & Nephew PLC, Lumenis Be Ltd., Merz Pharma GmbH & Co. KGaA, Cynosure, LLC, Molnlycke Health Care AB (Investor AB), Suneva Medical, Inc., Perrigo Company PLC, Sientra, Inc., Bausch Health Companies, Inc. and Alma Lasers (Sisram Medical Ltd.)

Global Scar Treatment Market Segmentation

By End-use

• Hospitals
• Clinics
• Retail Pharmacies/ E-commerce

By Product

• Topical Products
  • Creams
  • Gels
  • Silicon Sheets
  • Others
• Laser Products
• Injectables
• Others

By Scar Type

• Atrophic Scars
• Hypertrophic & Keloid Scars
• Contracture Scars
• Stretch Marks

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Smith & Nephew PLC
• Lumenis Be Ltd.
• Merz Pharma GmbH & Co. KGaA
• Cynosure, LLC
• Molnlycke Health Care AB (Investor AB)
• Suneva Medical, Inc.
• Perrigo Company PLC
• Sientra, Inc.
• Bausch Health Companies, Inc.
• Alma Lasers (Sisram Medical Ltd.)

Unique Offerings from KBV Research

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Related Reports:

North America Scar Treatment Market size & Opportunities 2022-2028

Europe Scar Treatment Market & Growth Forecast 2022-2028

Asia Pacific Scar Treatment Market Share & Industry Outlook to 2028

LAMEA Scar Treatment Market Growth, Trends & Forecasts 2022-2028